Integrating the results of user research into medical device development: insights from a case study by Martin, Jennifer L. & Barnett, Julie
Martin and Barnett BMC Medical Informatics and Decision Making 2012, 12:74
http://www.biomedcentral.com/1472-6947/12/74RESEARCH ARTICLE Open AccessIntegrating the results of user research into
medical device development: insights from a
case study
Jennifer L Martin1* and Julie Barnett2Abstract
Background: It is well established that considering users is an important aspect of medical device development.
However it is also well established that there are numerous barriers to successfully conducting user research and
integrating the results into product development. It is not sufficient to simply conduct user research, it must also be
effectively integrated into product development.
Methods: A case study of the development of a new medical imaging device was conducted to examine in detail
how users were involved in a medical device development project. Two user research studies were conducted: a
requirements elicitation interview study and an early prototype evaluation using contextual inquiry. A descriptive in
situ approach was taken to investigate how these studies contributed to the product development process and
how the results of this work influenced the development of the technology. Data was collected qualitatively
through interviews with the development team, participant observation at development meetings and document
analysis. The focus was on investigating the barriers that exist to prevent user data from being integrated into
product development.
Results: A number of individual, organisational and system barriers were identified that functioned to prevent the
results of the user research being fully integrated into development. The user and technological aspects of
development were seen as separate work streams during development. The expectations of the developers were
that user research would collect requirements for the appearance of the device, rather than challenge its
fundamental concept. The manner that the user data was communicated to the development team was not
effective in conveying the significance or breadth of the findings.
Conclusion: There are a range of informal and formal organisational processes that can affect the uptake of user
data during medical device development. Adopting formal decision making processes may assist manufacturers to
take a more integrated and reflective approach to development, which should result in improved business
decisions and a higher quality end product.
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Whilst it is well established in theory that considering
users and their requirements is an important aspect of
medical device development, in practice there is little
evidence of how this is done, how the results of this are
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Buckle et al. [1] makes the point that more case studies
that document the whole spectrum of success and fail-
ure in terms of integrating the results of user needs re-
search are essential. As a preface to presenting a case
study of user involvement in medical device develop-
ment and an analysis of the barriers to incorporating the
resultant knowledge in the device development process,
we will outline the imperatives to user involvement and
provide a brief overview of the barriers to achieving this.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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designed to fulfil the requirements, needs and capabil-
ities of their users. User involvement in medical device
development has been the focus of much recent research
[2-4]. The benefits of a user-centred approach to design
include improved patient safety [5], better health out-
comes [6] and increased user satisfaction [7]. It has also
been suggested that products that have been designed in
this way are more likely to be commercially successful
and less likely to require post-market alterations or
recalls [8]. To increase the likelihood of producing such
a device, developers must have a clear and thorough
understanding of, as appropriate, the clinicians, patients
and carers who will use the device. The range of physical
and organisational environments within which device
use will be embedded must also be considered.
There are three main factors that encourage and mo-
tivate developers to conduct user research during the
medical device development process (MDDP). The most
notable is the regulatory imperative; there are a range of
requirements that must be met before a device can le-
gally be placed on the market. Both the US Food and
Drug Administration (FDA) and the European Union re-
quire developers to demonstrate, normally through com-
pliance with standards, that they have adopted human
factors engineering processes (also known as human fac-
tors, ergonomics or user-centred design) throughout de-
velopment [9,10].
A second imperative is located in the requirements of
funders of healthcare technology research, whose fund-
ing decisions are, in part at least, contingent on develo-
pers promising to consult and actively involve device
‘users’ and ‘stakeholders’. This is particularly relevant for
Small and Medium Sized Enterprises (SMEs) who are
often dependant on this type of funding to support new
product development. In the UK in particular a signifi-
cant proportion of medical device development is under-
taken by SMEs, for example small engineering firms and
university spin-outs. These types of companies will typ-
ically have less access to in-house expertise in user re-
search and are therefore likely to be especially reliant on
securing external funding to allow them to conduct this
work.
Thirdly, there is a substantial literature on methods
for accessing user needs that is, in theory at least, avail-
able to device developers who wish to respond to these
imperatives and conduct user centred research as part of
the MDDP. This literature describes the theory behind
this approach [11]; how and when to conduct the work,
and with what groups of people [2,3,12].
It is also well-established, however, that there are bar-
riers to the involvement of users in this process. Draw-
ing on other areas of product development, it is clear
that some barriers are located in relation to the user.Van der Panne et al. [13] note that users have limited
ability to envision novelty and thus involvement is likely
to be biased toward imitative products and incremental
innovation. Other barriers are located at the organisa-
tional level. Developers may limit user engagement due
to resource constraints [3] or the belief that the invest-
ment required to conduct user research is not an effect-
ive use of limited resources [14]. The way in which user
needs data is delivered to the organisation may not
dovetail with their decision-making process about the
product [15,16]. Indeed the perspective of the user pro-
vided by formal methods may not chime with the repre-
sentations of the user held by developers themselves
[17]. In sum, such factors may limit the extent to which
user information is appropriated within the product de-
velopment process.
Any new product development project is a complex
process, regardless of the industry it is located in. In rec-
ognition of this, considerable research has been con-
ducted on how to effectively manage product
development projects, and how to use the information
collected during the project to make good business deci-
sions. The question here is, how can user data be effect-
ively collected, represented and utilised during the
product development process?
Empirical research has consistently shown that that
the factor most strongly associated with successful prod-
uct development is “the existence of a high-quality,
rigorous new product process: one that emphasizes up-
front homework, tough Go/Kill decision points, sharp
early product definition, and flexibility” [18]. The ‘stage-
gate’ model is the most frequently used such approach
[19] and aims to take the product from concept all the
way to market. At the beginning of a project the devel-
opment process is divided into ‘stages’ that consist of
related and parallel activities. At the end of each of these
stages there is a decision point or ‘gate’, when the man-
agement team reviews progress across all the different
strands of development and then takes a decision on
how the project should progress, or indeed, whether it
should progress. The ultimate aim of such an approach
is to ensure that objective and informed decisions are
made at each and every stage of product development,
based on careful consideration of all the information
available at that time. It has recently been suggested by
Pietzsch et al. [20] that the complex nature of medical
device development necessitates a formal stage-gate ap-
proach to development as this industry is characterised
by high technology development, strict regulatory
requirements and complex reimbursement processes.
In summary then, although human factors engineering
methods are potentially of value at every stage of the
MDDD process and documenting user involvement is
increasingly mandatory, in practice, manufacturers may
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MDDP process. If the full benefits of involving users are
to be realised, more primary research is needed to better
understand manufacturers’ perspectives and motivations
and also how the results of user research can be effect-
ively incorporated into the product development
process.
This paper presents a case study of a medical device
development project. The results are used to recom-
mend strategies for effective user involvement in medical
device development. We also examine the wider implica-
tions of these findings for medical device manufacturers,
research funders and policy makers.
Methods
Case study
The development of a new medical imaging device was
studied using a descriptive approach, as described by Yin
[21]. The objective was to study in situ a process of user
involvement in medical device development in order to
explore how user facing work was done across the prod-
uct development process; characterise the approach, atti-
tude and expectations of the developers; and identify
barriers to the implementation of the research results.
Data collection and analysis
Data in the case study were collected by a variety
of methods:
 Semi-structured interviews were conducted with
members of the development team at various points
throughout development.
 Participant observation at development meetings.
 Document analysis of (for example) meeting
minutes, project plans and technical reports.
Ethical considerations
The research described in this paper received ethical ap-
proval from the NHS Nottingham Research Ethics Com-
mittee 2 (ref 09/H0408/15).
Background to case study
In 2005 a development team was awarded a grant of ap-
proximately £1 M from the UK Technology Strategy
Board (formerly the Department of Trade and Industry)
to develop a new medical imaging device. The original
project plan was that development would run for
36 months, however, due to delays, this was extended to
48 months. The project team consisted of 9 individuals
of different specialities from 5 organisations. The project
was led by the managing director of the lead organisa-
tion: a SME medical device developer, with a track rec-
ord in biomedical instruments. The device was one of a
small number of development projects within thecompany. At the end of the development project, the
lead organisation would be responsible for commercia-
lising the device (with appropriate licensing contracts
with the other participating organisations).
The device
For reasons of commercial confidentiality it is not pos-
sible to describe the technological details of the medical
device developed in the study. In brief however, the de-
vice uses laser Doppler technology to produce images of
various body areas, with the aim of providing an inex-
pensive, portable device that will enable healthcare pro-
fessionals to perform common procedures more
successfully and efficiently and with less pain and dis-
comfort to patients.
Project plan
The original project plan consisted of five ‘work
packages’:
 WP1: Development of initial imaging system (lab-
based) Months 1 – 6
 WP2: Laser developments (lab-based) Months 1–16
 WP3: Optimisation of algorithms through testing
technology on volunteer patients. Months 1 – 6
 WP4: Development of imaging system. Months 6–
30
 WP5: Evaluation of imaging system: evaluate
technological performance on a range of patients;
obtain user feedback and assessment of device.
Months 22–36.
The first ‘active’ participation of users was planned
during WP5 with passive involvement of patients
planned during WP3. In the grant application the devel-
opers stated that they intended to involve clinical users
in development:
“Data will be collected from the hospitals and there
will be consultations with nurses, phlebotomists and
doctors in the evaluation process (WP5)”.
The project plan identified a number of interdepend-
encies between the work packages however these were
between the technological aspects. No areas of develop-
ment were identified as being contingent on user feed-
back about the device.
In month 2 of the project the lead author (JM) joined
the development team to provide expertise on conduct-
ing user research. On inspection of the project plan JM
recommended that a more formal and rigorous ap-
proach to user research should be taken that would
allow functional and user requirements to be collected.
As a result of this, an additional work package was
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via interviews with medical staff”. This was thus the first
user-related work to be conducted. Again, no formal
links or dependencies from this WP for future work
were identified.
We now briefly describe the two user research studies
in WP0 and WP5. For a full description of these investi-
gations please refer to Martin et al. [22] and Martin
et al. [23].
Results of User Research
Requirements elicitation (WP0)
The aims of the first phase of user research were devel-
oped by JM following discussions with the project team.
The developers stated that the main objective of this
work should be to collect the opinions of healthcare staff
that would use the device on its design: how it should
look, what size and shape it should be and how it should
display data. The project team also stated they were
interested in information about the work patterns of
healthcare staff. JM used these discussions as well as
principles of user-centred design [24] to produce the fol-
lowing objectives:
 Identify the clinical need for the new device and
identify target clinical and patient users
 Identify any potential barriers to safe and effective
use of the device.
 Collect user opinions on the design of the new
device
When deciding on the focus of this study, it was
acknowledged that for any medical device there are
likely to be many different types of users, and that all of
these groups should be considered during development.
For this device, the ‘users’ will include not only the
operators of the device but also the patients who will be
treated by the device. In addition, the requirements of
the people that will be responsible for maintaining,
cleaning and setting up devices should also be consid-
ered. As the aims of this initial study were to identify the
clinical need for the device and investigate its effective-
ness and usability in the clinical environment it was
decided that clinical staff should be the focus as they
would be the potential device operators. In addition, as
the primary aim of the research was to identify the
patients most likely to benefit from the device, it was felt
that clinicians would be an appropriate proxy for patient
views at this point in development as they would be able
to draw on their experiences of treating a wide range of
patients from a variety of clinical areas.
All potential clinical users of the device were identified
during a brain-storming session with the development
team. An interview study was then undertaken with apurposive sample of representatives of each of the identi-
fied user groups: a range of healthcare professionals from
the following clinical departments: renal, oncology, inten-
sive care, neonatal, clinical research and phlebotomy.
47 individual, semi-structured, face-to-face interviews
were conducted at 2 UK NHS hospitals. Each interview
lasted between 23 and 44 minutes and covered:
 Problems that clinical users encountered, their
causes and consequences
 The perceived need for the proposed device
 The clinical environment within which the device
would be used (physical and organisational).
Data analysis was performed by JM and was organised
according to the 3 main aims of the study: clinical need;
barriers to adoption; design features. A written report
(39 pages with 3 page executive summary) was circu-
lated to the project team in Month 16 of the project and
the main findings were presented to the team during the
next scheduled development meeting (Month 17).
The most significant finding of the requirements
elicitation study was in relation to the clinical need for
the proposed device. The responses of the clinical users
strongly suggested that the concept for the device
should be changed in two main ways. Firstly in relation
to the target users for the device, the research sug-
gested that the original concept over-estimated the clin-
ical need for the device from the phlebotomy patients.
The interviews in the neonatal, clinical research and in-
tensive care departments revealed that there was not a
significant need for the device, although the staff did
report that there may be some applications where it
could be of some use. However, a number of previously
unknown clinical needs in renal care and oncology were
identified, suggesting that these areas should be the
focus of device development. Second, in relation to the
characteristics of the device, the original concept had
stated that an important priority was to provide a de-
vice that was light and highly portable. However, the
interviews suggested that it would be the time required
to set-up the device and obtain an image that would
most significantly affect uptake and effective use by
clinicians.
The feedback from the development team following
the initial presentation of the results was positive. They
noted the insights that had been gained and there was
ostensible agreement about the implications of these for
the development process.
“After the interviews it seems that that application is
quite limited so the fact that it identified different
markets is a big positive part (of the research)”. Team
member 2
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thing and that’s a new challenge that we didn’t know
about before. That’s going to have to be a priority of
the hardware and software development.” Team
member 2
Despite this, development of the device continued
according to the original project plan. No formal oppor-
tunities were created for discussing the implications
these findings might have for the development of the
technology. When discussed at later project meetings,
the informal responses to the interview data was that it
would be considered more fully within the commercial-
isation plan at the end of the project once the technol-
ogy had been developed.
Prototype evaluation (WP5)
The second user research study was conducted, accord-
ing to the initial plans, as part of the prototype device
evaluation in WP5. The protocol was developed by JM
following discussions with the development team. Based
on well-established user-centred design principles the
broad objective to ‘obtain user feedback and assessment
of device’ [24] was extended to critically evaluate the
prototype imager within the clinical environment to
investigate:
 The usability of the device in the clinical
environment
 Environmental and organisational barriers to safe
and effective use of the device
 Opinions of users on the design of the device and
the display of data
This study used an adapted form of contextual inquiry
[25], an observational research method with its roots in
ethnography - to study a total of 12 users (healthcare
staff ) as they used the device during patient consulta-
tions. The researcher (JM) shadowed each user as they
took images from the patient and encouraged them to
describe what they were doing and why, and asking for
clarification where required. Users were encouraged to
describe their interactions with the device: for example
how useful they found it and whether they were experi-
encing any difficulties or frustrations.
This research identified a number of factors relating to
the physical and organisational characteristics of the en-
vironment and characteristics and capabilities of clinical
users and patients that would affect the use of the de-
vice. It was clear that the physical environment had a
significant effect on the usability of the device. The de-
vice was used in a variety of areas, including individual
consulting rooms of varying dimensions, and healthcare
staff were observed having clear difficulties whenmanoeuvring the device in the smaller consulting rooms
and in the presence of other medical equipment. Many
patients had mobility problems or clinical conditions
that made it difficult or uncomfortable for them to get
into the position required to allow an image to be taken.
It was also evident from the study that operational and
clinical requirements would affect uptake of the device;
it was a clear priority for the clinical participants to
complete the patient consultations as quickly and effi-
ciently as possible. Many expressed frustration with the
length of time it took to set up and manoeuvre the de-
vice before an image could be taken. Patients also fre-
quently expressed their desire to be treated quickly so
that they could go home also suggesting that the time
taken to operate the new device would affect its uptake.
Due to other work packages running over schedule a
working prototype of the new device was not available
for testing until the final months of the project. This
meant that that the prototype evaluation did finish until
the final (48th) month of the project and therefore was
no opportunity for the researcher to formally present
the full results. Following the end of the project, the de-
velopment team requested the images taken from the
patients during the evaluation for inclusion in the final
report to the research funders and for their own records.
The other findings from the evaluation were not
requested and therefore the information on usability and
clinical and operational requirements was not reported
to the project team. No presentation of the results –for-
mal or informal - was invited, which suggests that the
developers did not perceive this information as import-
ant or likely to affect the decisions made about the fu-
ture development of the technology.
Summary of user research
The results from the user research performed were clear
and consistent: there was a clinical need for the pro-
posed device although this need was substantially differ-
ent to the one that had been identified at the beginning
of the project. The researcher recommended that the
concept for the device should be changed to focus on
the clinical need of renal and oncology patients and the
requirements of the healthcare staff working in these
areas. In addition, the prototype evaluation identified a
number of factors related to the physical and operational
characteristics of the clinical environment that would
affect uptake and long-term use of the device, most not-
ably, the time required to obtain an image.
The results of the user research were fed back to the
development team in a number of ways. Following the
requiring elicitation study the development team was
sent a detailed written report which included a break-
down of the results according to a range of factors in-
cluding: job role, clinical speciality, size of organisation
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presentation of the main findings to the whole develop-
ment team. The researcher engaged informally with
the development team throughout the whole project, up-
dating the lead organisation on the progress and initial
findings of the user research via e-mail. In addition, the
researcher attended the development meetings (held
every 3 months), where she updated the team on the
findings of the user research and made recommenda-
tions for development based on the findings of this
work.
The recommendations from the user research studies
did not have a significant impact on the development
process. Whilst the company ostensibly agreed with the
results of the user needs research, the development team
were happy for product development to continue in line
with the original plan and thus the focus was clearly on
developing the imaging technology and improving the
reliability and quality of the images. The feedback from
the team was that the user research data would be useful
in the later stages of development.
The full results of the prototype evaluation were not
reported formally to the development team, which was
largely due to the fact that the study was delayed and
the results were not available until the end of the pro-
ject. It is interesting to note however that, although the
lead organisation requested the device images that had
been collected during this study, they did not also re-
quest the results of the usability testing. This suggests
that the developers did not view this information as
being factors that could potentially influence the deci-
sions made about the future of the technology.
Project outcome
Following completion of the 48 month project the lead
organisation is currently considering the next step for
the new medical device. The most appropriate route for
commercialisation is being considered: this may be to
continue to produce a clinical device or it could be to
focus on producing a device for clinical research, which
would be a simpler, but less lucrative, route to commer-
cialisation. New funding and investment is being sought
to support the next stages of development.
Discussion
Our case study has focused on the user research that
ran alongside the development of an imaging device and
has considered the way in which the results of this were
taken into account by the company. The final stages of
this development project are still to unfold and therefore
we are not able to draw firm conclusions as to whether
these issues were a significant factor in the success or
failure of this device. However the focus of this paper
has been one exploring the way in which user needsresearch was or was not integrated into the product de-
velopment process and this focus is distinct from the
issue of whether or not the product ultimately proves to
be a success.
It is difficult to draw any firm conclusions as to
whether greater consideration of the results of the user
research would have benefitted this project. However, a
number of the user requirements that were identified in
the early user research were at variance with the direc-
tion and focus of technological development. For ex-
ample, it was determined at the beginning of the project
that the device should be portable so that it could be
carried around by healthcare staff; the phrase “cam-
corder sized” was frequently used by the development
team. As a result a main focus of the technological de-
velopment was on developing a device that was light and
small. However, the interview data suggested that
manoeuvrability at the point of capturing the image was
more important than portability. The clinical users
reported that getting the device to patient’s side would
not be a the problem, as organisational protocols meant
that it would be likely that the device would stay in a
particular clinic or department, but that once the device
was next to the patient it would be essential that the de-
vice could be easily positioned to quickly capture the
image of the required body area. This suggests that the
effort and investment that was directed to the consider-
able technological challenge of producing a small device
may have been a poor use of resources.
There was no evidence that the user research had a
significant effect on the subsequent product develop-
ment process. Our analysis of this case study suggests
that a range of factors can be identified as contributing
to this situation.
Integration of user needs with technology development
It was clear that the user needs part of the product de-
velopment process was viewed as an isolated part of the
project and separate to the technology development.
The evidence provided by the requirements elicitation
study was not integrated with the technology develop-
ment process. This was also observed at the end of the
project, when the developers requested the technical
results of the prototype evaluation but not the results of
the usability evaluation.
This chimes with the work of Chess [26] who provides
a useful framework for exploring organisational respon-
siveness. She conceptualises the possible impact of or-
ganisational structure and processes on the way in
which knowledge is exchanged within an organisation –
and thus on the impact that this knowledge has on or-
ganisational actions. A key determinant of this is how
different organisational functions are ‘coupled’, i.e. the
way in which one function constrains another. In the
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it is clear that the user-facing functions (or at least those
that are formally oriented around user needs) were loosely
coupled to those that were related to development of the
technology. The two different functions did not constrain
the other, with each able to proceed independently of the
other. This was evidenced by the lack of planned inter-
dependencies between the user research and the rest of
development. This is exemplified by the fact that at the
end of the project, the technical results of the prototype
evaluation were requested but not the usability results,
suggesting that the developers did not believe that the us-
ability results would affect future decisions about the de-
velopment of the technology. There are a number of
reasons why this type of situation may exist during the
product development cycle. Within large organisations
different aspects of development will often be performed
by dedicated and separate departments and if there is poor
communication or a lack of interaction between depart-
ments this could result in different aspects being de-
coupled. Within a small company or a close-knit project
team, such as the one in the case study, this type of situ-
ation should be less likely to occur as there should theor-
etically be greater involvement and awareness by all of the
developing research results. However, although this was
the case in this case study, there seemed to be consensus
within the development team that the user needs research
was not a critical aspect of development and that the
results of this work would not significantly influence the
development of the technology. As a result no contingen-
cies in relation to the user needs work were identified.
We suggest that adopting a formal new product
process to monitor progress and aid decision making
may have led to improved integration of the different
strands of this development project. The use of such
processes has consistently been shown to be associated
with successful product development across a variety of
industries [27]. It is noteworthy that the funders of this
research – the UK TSB, who support innovation in UK
business by investing more than £500 million each year
– did not either require or recommend that the project
team adopt such a strategy for ensuring due consider-
ation is given to the results of the user related research
that is required.
Framing research aims
Arguably the way in which the aims of the user research
were framed by the development team was inappropri-
ate, both in relation to the characteristics of users and
the timing of the research.
Characteristics of users
In the original product development plan no early stage
of capturing clinical needs was planned. Although thedevelopers were open to this when it was suggested, they
believed that the main aim of user research was to iden-
tify design features for the new device to inform the de-
velopment of a prototype. This was thus the primary
aim of the requirements elicitation. The results of the
case study demonstrate that this was a somewhat unreal-
istic aim. The data collected from the interviews indi-
cated that users primarily expressed their reflections on
the device in terms of the needs, difficulties and pro-
blems that they experienced. These findings support pre-
vious research that has shown that users find it difficult
to provide design suggestions, particularly when un-
prompted by an existing prototype, as this requires a
high degree of foresight [28,29]. It has also been shown
that this is a particular issue for radical innovations
when users do not have knowledge or experience of a
similar existing product to draw on [30], which was the
case with this study. Unsurprisingly, in reflecting on de-
sign features, users are also likely to draw heavily upon
the contexts in which would they be required to use the
device.
From this, we propose that the strategy of developers
at the early stages of medical device development should
be on identifying clear clinical needs and requirements.
Once this has been done it is then the role of the develo-
pers and designers to provide a device that provide solu-
tions to these needs, which can then be tested and
evaluated by users and hopefully provide the required
triggers for a discussion of potential improvements and
refinements. In reality of course, many devices are the
outcome of a new technological capability and a match-
ing clinical need then needs to be found to allow exploit-
ation of this. In these circumstances it is arguably all the
more important that formal processes that allow the in-
tegration of revealed clinical needs with technological
development are adopted.
Timing of research
The user research commissioned by the development
team did meet one of the main recommendations of the
guidance and literature in this area: that research should
be conducted early in the development process [31].
However our results suggest that this was negated by
the lack of mechanisms for feeding the data into a prod-
uct development process that was dominated by techno-
logical requirements.
The results of the requirements elicitation suggested
that the fundamental concept for the device should be
changed. The nature and scope of these findings was not
anticipated by the developers. They rather believed that
the results would confirm their belief on the clinical
need for the device and provide a consensus on what the
look and feel of the device should be. This suggests that
it would be valuable for those doing user focused
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of findings (for example, that the clinical need is differ-
ent than anticipated, that unanticipated features of the
device are of importance etc.). By the same token, devel-
opers need to consider and articulate what their latitude
is for taking account of such findings within the product
development process. Clearly it is naive to expect that
all findings can be taken on board. Where time or
money preclude a change in direction however, it is ar-
guably important to document how and why this deci-
sion has been made as part of the formal stage gate
process so that information is made available throughout
and decisions revisited if necessary. Such a process also
allows possible risks to commercial success to be identi-
fied and documented so that they can be monitored as
development continues.
In our case study it appeared that neither the organisa-
tional culture nor the project management processes
facilitated full consideration of the implications of the
research results. That the developers did not expect the
results to significantly contradict their beliefs was pos-
sibly due to their lack of familiarity with this type of re-
search as well as to the researcher not making the
potential impact of the research on the development
plan clear. The researcher did not explicitly describe the
scope and implications of the work, nor pose the ques-
tion as to what they would do if the results were not in
line with their expectations.
Even where developers are not aware of the potential
benefits of user needs research a formal stage gate
process would provide the opportunity for objective re-
view of the research and clear documentation of the
decisions that have been made on the basis of it. In this
domain, where the assumption is that technological de-
velopment has primacy, such a process provides a formal
opportunity to articulate whether the user needs re-
search that has been conducted requires any subsequent
change in the development pathway.
Significance of user research results
Another possible reason for the user research results not
being fully adopted by the development team may have
been the degree to which the findings contradicted the
concept for the device. The concept, developed as the
result of informal discussions with a small number of
clinicians, had been the basis for planning the entire
project, including securing the funding and as a result it
is reasonable to assume that the developers were com-
mitted to this concept. It is possible therefore that cogni-
tive biases, specifically confirmation bias, may have
affected how the development team processed the
results of the user research, which contradicted this con-
cept. Confirmation bias, identified by Nickerson [32] as
the “single problematic aspect of human reasoning thatdeserves attention above all others”, is a well-established
phenomenon where decision makers have been shown
to search for or interpret information in a way that con-
firms their hypothesis, and place less importance or ig-
nore evidence that would contradict it [33]. This may
also explain why the developers did not request the
complete results of the second user research study.
Another cognitive bias that may also have affected
how the results were processed is Status Quo Bias [34]:
the tendency to maintain the status quo when faced with
a complex decision. Recent research on this phenomena
has shown that the more difficult the decision, the more
likely it is that the decision-maker will do nothing and
maintain the status quo [35].
Again, adopting a formal new product process may be
a strategy to counter this, resulting in a more objective
approach being taken to the synthesis and uptake of re-
search evidence. This is arguably even more pertinent
for SME developers where there are likely to be fewer
people involved in the development of each device per-
haps leading to less objectivity during decision making.
Communicating research results
The way that the results of the first user research study
were disseminated to the development team by the re-
searcher (JM) may not have been effective in conveying
the significance or breadth of the data. The full results
were contained in a lengthy document that would have
been time consuming for the development team to read
and may also have led to the quotes losing some of their
significance due to being presented as text. Playing the
audio clips of these quotes may have been a more effect-
ive at conveying this information. In addition, although
the most significant findings of the requirements elicit-
ation were presented in a presentation to the develop-
ment team by JM, this was done during a normal project
meeting where it was one item on a full agenda. It may
have been more effective to have scheduled a special
meeting where the development team had more time to
listen to and discuss the results.
Related to this issue is the fact that the user research
was performed by an external researcher who was re-
sponsible for disseminating the information to the devel-
opment team. It has been suggested that such an
approach is undesirable as it inevitably results in some
filtering and distortion of the information [36,37] and
that developers should be brought into direct contact
with users rather than merely hearing or reading about
them through intermediaries [38]. In addition to this,
the risk and rewards of commercialising this device lay
mainly with the lead organisation and therefore it is pos-
sible that the external researcher was not sufficiently
motivated to reinforce the results of this work and to
press for their prioritisation during development. It is
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velopment projects when contracting user research (or
other aspects of development) to external consultancies.
It is the responsibility of the developer to establish pro-
cesses that will allow all information streams to be heard
and appropriately prioritised.
Nature of obligations to conduct user research
The main motivation for including user research a part
of this project was that it was a requirement of the re-
search funders. It is of note, however that although the
plan for the user research proposed by the development
team during the application process was extremely brief
and vague, this met the funding requirements. No
recommendations or guidance were provided to the
developers as to what might constitute meaningful user
research, nor was any evidence needed that the results
of this research would be considered within the product
development process.
The present research has suggested that it is not suffi-
cient to plan to conduct user research and that this
should not serve as the ‘trump card’ for funding applica-
tions. Indeed we would argue that the current simplistic
requirement of some funders and regulators that users
should be involved in the product development process
may in fact be counterproductive. It may lead to this
work becoming a box-ticking exercise, conducted to sat-
isfy funders, rather than being a thoughtful consider-
ation of how to conduct user research that firstly, allows
the necessary information on user needs and require-
ments to be collected and secondly, allows the best
product development decisions to be made. Taking this
further, one might suggest that where user research is
framed inappropriately (e.g. focusing on detailed device
characteristics) that this may lead to the development
path becoming more set and less amenable to change
(greater lock-in) than if the user research was not done
at all. It is our position that research funders should
focus more on ensuring that the aims, approach, timing
and integration of user research are appropriately speci-
fied and that the development decisions that are made
on the basis of the research are visible.
Often the need for confidentiality leads to a reluctance
to publish results and this leads to a lack of knowledge
development in this area. We concur with Buckle [1]
that a growing body of evidence and good-practice
examples in this area would lead to a raised awareness
amongst developers of how to effectively conduct and
manage user research as part of a wider product devel-
opment process.
Finally it is useful to reflect on what ‘good’ user needs
research looks like. In this case study, in the final ana-
lysis it was not rated highly by the developer simply be-
cause the results it produced did not concur withdeveloper expectations. In the development of technol-
ogy there is a clear end point - acceptable functionality –
yet the process by which this is reached remains largely
invisible. In contrast, the end point of user needs re-
search is unknown; rather research quality is a function
of the process. Researchers should make developers
aware that the research they conduct should be subject
to evaluation and scrutiny in relation to the rigour of the
process of data collection and analysis rather than on the
substance of the findings per se.
Recommendations
1. The guidance currently available to developers is
somewhat simplistic. Funders of medical device
research and development should provide
developers with more detailed guidance on how to
design effective user research studies. For example,
what the aims of research at each stage of
development should be, how it should be conducted,
and what the implications of the research may be.
2. User research in the early stages of medical device
development should be kept broad and aim to ‘open
up’ device considerations with a focus on identifying
as many clinical needs as possible. Developers
should wait until a prototype is available before
collecting user opinions on specific design features.
3. A formal new product process such as a stage-gate
model should be adopted that allow for articulation
and documentation, at pre-determined points, of the
contingencies between technological development
and the decisions that are made about user
requirements.
4. Developers should take care when contracting out
parts of development that these are objectively
appraised and considered by, for example, a senior
member of the development team becoming a
‘champion’ for this work.
Conclusion
In contrast to most research in this area, this case study
has provided the opportunity to explore the implemen-
tation of user needs research within a small medical de-
vice development project. In so doing we have identified
numerous barriers to the implementation of user needs
research that result from both formal and informal or-
ganisational processes. We have suggested the value of a
formal decision making process in encouraging a process
of reflection on the implications of user needs research
for product development that may result in a more ob-
jective approach to decision making based on all avail-
able information. Locating funding requirements in this
area would arguably lead to a more meaningful and real-
istic assessment of how, if at all, information about user
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ment process. Finally, the findings of this paper should
be communicated by academia and also by industry bod-
ies such as the Association of British Healthcare Indus-
tries (ABHI) in order to improve practice throughout
the wider medical device industry.
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